Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer

Documenti analoghi

• A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer
  di: Hongtao Duan, et al.
  Pubblicazione: (2024)
• Camrelizumab combined with gemcitabine and apatinib in treating advanced PD‐L1‐positive biliary tract cancers
  di: Yitong Tian, et al.
  Pubblicazione: (2024)
• Phase I trial of apatinib and paclitaxel+oxaliplatin+5‐FU/levoleucovorin for treatment‐naïve advanced gastric cancer
  di: Shen Zhao, et al.
  Pubblicazione: (2024)
• Utilization and survival outcomes of neoadjuvant chemotherapy for early‐stage gastric cancer
  di: Lauren M. Janczewski, et al.
  Pubblicazione: (2024)
• Efficacy and safety of Brucea javanica oil soft capsules combined with oral chemotherapy for maintenance therapy in advanced gastric cancer
  di: Yingying Kou, et al.
  Pubblicazione: (2025)